Cytotoxicity of histocompatibility leukocyte Antigen-DR8-restricted CD4+ killer T cells against human autologous squamous cell carcinoma

Japanese Journal of Cancer Research

Volumn 88, Issue 2, 1997, Pages 191-197

  Miyazaki, Akihiro ^a   Sato, Noriyuki ^a   Takahashi, Shuji ^a   Sasaki, Aya ^a   Kohama, Gen Iku ^a   Yamaguchi, Akira ^a   Yagihashi, Atsuhito ^a   Kikuchi, Kokichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autologous tumor; Fas antigen; HLA DR8; Squamous cell carcinoma

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; HLA DR ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; KILLER CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

EID: 0030937570     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00365.x     Document Type: Article

References (38)

1. Sato, T., Sato, N., Takahashi, S., Koshiba, H. and Kikuchi, K. Specific cytotoxicity of a long-term cultured T-cell clone on human autologous mammary cancer cells. Cancer Res., 46, 4384-4389 (1986).
2. Okubo, M., Sato, N., Wada, Y., Takahashi, S., Torimoto, K., Takahashi, N., Sato, T., Okazaki, M., Asaishi, K. and Kikuchi, K. Identification by monoclonal antibody of the tumor antigen of a human autologous breast cancer cell that is involved in cytotoxicity by a cytotoxic T-cell clone. Cancer Res., 49, 3950-3954 (1989).
3. Wada, Y., Ikeda, H., Ueda, D., Ohta, M., Takahashi, S., Hirata, K., Sato, N. and Kikuchi, K. In vitro proliferation and the cytotoxic specificity of a cryopreserved cytotoxic T cell clone reacting against human autologous tumor cells. J. Immunol. Methods, 154, 235-243 (1992).
4. Wada, Y Ikeda, H., Ueda, D Ohta, M Takahashi, S Hirata, K Sato, N. and Kikuchi, K. Brefeldin A blocks the cytotoxicity of T cell receptor α/β and γ/δ cytotoxic T lymphocyte clones reacting against human autologous cancercells.Jpn. J. Cancer Res 84, 906-913 (1993).
5. Yasoshima, T Sato, N., Hirata, K. and Kikuchi, K. The mechanism of human autologous gastric signet ring cell tumor rejection by cytotoxic T lymphocytes in the possible context of HLA-A31 molecule. Cancer, 75, 1484-1489 1995).
6. Crowley, N. J Darrow, T. L Quinn, A. M. and Seigler, H. F. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J. Immunol 146, 1692-1699 1991).
7. Ioannides, C. G Freedman, R. S Platsoucas, C. D Rashed, S. and Kim, Y. P. Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J. Immunol 146, 1700-1707 1991).
8. Mukherji, B Guha, A., Chakraborty, N. G Sivanandham, M Nashed, A. L Sporn, J. R. and Ergin, M. T. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J. Exp. Med 169, 1961-1976 1989).
9. van der Bruggen, P Traversari, C., Chomez, P Lurquin, C De Plaen, E van den Eynde, B Knuth, A. and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643- 1647 1991).
10. Yasumura, S Hirabayashi, H., Schwartz, D. R Toso, J. F Johnson, J. T Herberman, R. B. and Whiteside, T. L. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res 53, 1461-1468 1993).
11. Brichard, V van Pel, A., Wolfel, T Wolfel, C De Plaen, E Lethe, B Coulie, P. and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med 178, 489-495 (1993).
12. Traversari, C van der Bruggen, P., Luescher, I. F Lurquin, C Chomez, P van Pel, A De Plaen, E Amar-Costesec, A. and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.J. Exp. Med 176, 1453-1457 1992).
13. Gaugler, B van den Eynde, B., van der Bruggen, P Romero, P Gaforio, J. J De Plaen, E Lethe, B Brasseur, F. and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med 179, 921-930 (1994).
14. Mandelboim, O Berke, G., Fridkin, M Feldman, M Eisenstein, M. and Eisenbach, L. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature, 369, 67-71 (1994).
15. Cox, A. L Skipper, J., Chen, Y Henderson, R. A Darrow, T. L Shabanowitz, J Engelhard, V. H Hunt, D. F. and Slingluff, C. J. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science, 264, 716-719 (1994).
16. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA, 91, 9461-9465 1994).
17. 4+ T-cell clones from regional lymph nodes of melanoma patients. Int. J, Cancer, 51, 218-224 (1992).
18. + T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15. J. Immunol 154, 772-779 1995).
19. + T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int. J. Cancer, 58, 69-79 (1994).
20. Sato, T Okubo, M., Wada, Y Sato, N. and Kikuchi, K. Identification of a human T cell clone with the cytotoxic T lymphocyte and natural killer-like cytotoxic function against autologous mammary carcinoma and K562 line. Jpn. J. Cancer Res 80, 655-661 (1989).
21. Yokoi, T Hirata, S., Nishimura, F Miyakawa, A Odajima, T Kohama, G. and Mochizuki, Y. Some properties of a newly established human cell line derived from an oral squamous carcinoma. Tumor Res 25, 93-103 (1990).
22. Takei, T Ishii, Y., Kon, S Fujimoto, J. and Kikuchi, K. Determinant heterogeneity of CDS, CD8 and CD4 antigen molecules as defined by monoclonal antibodies. Leukocyte Typing II, 1, 243-255 (1986).
23. Kayagaki, N Kawasaki, A., Ebata, T Ohmoto, H Ikeda, S Inoue, S Yoshino, K Okumura, K. and Yagita, H. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med 182, 1777-1782 1995).
24. Takahashi, S Sato, N., Takayama, S Ichimiya, S Satoh, M Hyakumachi, N. and Kikuchi, K. Establishment of apoptosis-inducing monoclonal antibody 2D1 and 2D1resistant variants of human T cell lines. Eur. J. Immunol 23, 1935-1941 1993).
25. Maecker, H. T. and Levy, R. Prevalence of antigen receptor variants in human T cell lines and tumors. J. Immunol 142, 1395-1404 1989).
26. Yokoi, T Yamaguchi, A., Odajima, T. and Furukawa, K. Establishment and characterization of a human cell line derived from a squamous cell carcinoma of the tongue. Tumor Res 23, 43-57 (1988).
27. Ikeda, H Sato, N., Matsuura, A. and Kikuchi, K. Analysis of T cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas. Cancer Res 53, 3078-3084 1993).
28. Ikeda, H Sato, N., Matsuura, A Sasaki, A Takahashi, S Kozutsumi, D Kobata, T Okumura, K Wada, Y Hirata, K. and Kikuchi, K. Clonal dominance of human autologous cytotoxic T lymphocytes against gastric carcinoma: molecular stability of the CDR3 structure of the TCRαβ gene. Int. Immunol 8, 75-82 (1996).
29. Kaneshige, T Hashimoto, M., Matsumoto, Y Kinoshita, T Hirasawa, T Uchida, K. and Inoko, H. Serologie and nucleotide sequencing analyses of a novel DR52-associated DRB1 allele with the DR "NJ25" specificity, designated DRB1*1307. Hum. Immunol 41, 151-159 1994).
30. Wolfel, T Hauer, M., Klehmann, E Brichard, V Ackermann, B Knuth, A Boon, T. and Meyer, Z. K. B. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL). Int. J. Cancer, 55, 237-244 (1993).
31. Kawakami, Y Eliyahu, S., Delgado, C. H Robbins, P. F Rivoltini, L Topalian, S. L Miki, M. and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91, 3515-3519 1994).
32. Coulie, P. G Brichard, V., van Pel, A Wolfel, T Schneider, J Traversari, C Mattei, S De Plaen, S Lurquin, C Szikora, J.-P. and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med 180, 35-42 (1994).
33. Nuchtern, J. G Biddison, W. E. and Klausner, R. D. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature, 343, 74-76 (1990).
34. Kagi, D Vignaux, F., Ledermann, B Burki, K Depraetere, V Nagata, S Hengartner, H. and Golstein, P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science, 265, 528-530 (1994).
35. Lowin, B Hahne, M., Mattmann, C. and Tschopp, J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature, 370, 650-652 (1994).
36. + T cell-mediated cytotoxicity. J. Immunol 152, 1127-1133 1994).
37. Rudensky, A Preston, H. P Hong, S. C Barlow, A. and Janeway, C. J. Sequence analysis of peptides bound to MHC class II molecules. Nature, 353, 622-627 (1991).
38. Nuchtern, J. G Bonifacino, J. S Biddison, W. E. and Klausner, R. D. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature, 339, 223-226 (1989).